Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
113.91
-0.32 (-0.28%)
Mar 19, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.35 billion as of March 20, 2026. Its market cap has increased by 437.85% in one year.
Market Cap
1.35B
Enterprise Value
1.30B
1-Year Change
437.85%
Ranking
Category
Stock Price
$113.91
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.35B, an increase of 836.51%. That is a compound annual growth rate of 494.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 1.53B | 23.54% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.37B |
| MBX Biosciences | 1.35B |
| Zenas BioPharma | 1.35B |
| Biohaven | 1.34B |
| Ardelyx | 1.34B |
| Rapport Therapeutics | 1.31B |
| Vir Biotechnology | 1.31B |
| Taysha Gene Therapies | 1.31B |